Previous studies have found that COL4A2 may be a tumor biomarker that promotes tumor metastasis and proliferation, which is highly expressed in liver preneoplastic lesions, such as fibrosis and cirrhosis (Chen et al., 2014; Dang et al., 2019). This evidence concerns the gene COL4A2 and Cirrhosis.